EIDP, Inc. · CTA-PA · FY2025 Q1 · Calendar Q2 2025
Corteva Holds 2025 Outlook as Q1 Growth Meets Tariff and FX Risks
The supplied call analysis points to improved Q1 operating performance and a maintained full-year outlook, with cost execution, out-licensing and growth platforms cited as supports. Tariff exposure, currency headwinds and crop-protection pricing pressure temper that constructive picture; guidance is an objective, not evidence of future delivery.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
unavailableAsk FN2 about CTA-PA FY2025 Q1
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, this call reports Q1 EBITDA growth and margin expansion and maintains full-year guidance. It also quantifies an approximately $50 million 2025 tariff impact, excluded from guidance; the prior analysis had identified tariff exposure as a risk without this quantified estimate.
Guidance delta
Management maintained FY2025 EBITDA guidance of $3.6–$3.8 billion. The approximately $50 million tariff impact is excluded from that guidance.
Key takeaways
- Q1 EBITDA increased 15% year over year, with roughly 400 basis points of margin expansion, according to the call analysis.
- Management maintained full-year EBITDA guidance of $3.6–$3.8 billion.
- Seed out-licensing reduced net royalty expense by $20 million, while biologicals and newer crop-protection products recorded double-digit volume gains.
- The approximately $50 million 2025 tariff impact is excluded from guidance; currency and pricing pressures remain risks.
Management priorities
- Continue seed out-licensing and expand the strategy for corn and soybean traits.
- Deliver the stated $400 million net cost improvement and $65 million royalty-neutrality benefit.
- Develop the hybrid wheat program, with a targeted 2027 launch, and expand the winter-canola pilot.
- Pursue growth in biologicals and new crop-protection products.
Follow CTA-PA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeCompany context
Snapshot as of publicationEIDP, Inc. is an agricultural enterprise focused on creating and providing commercial seed and crop protection products. Its operations span across a wide global area, encompassing the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. The company's business is structured into two main divisions: Seed and Crop Protection. Through its Seed segment, EIDP, Inc. offers a variety of products including corn, soybean, and other oil seeds. This division also develops innovative trait technologies that enhance crops' natural defenses against challenging weather, diseases, insects, and herbicides used for weed control.…
Historical context
All CTA-PA earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SQM Sociedad Química y Minera de Chile S.A. | FY2026 Q3 · Calendar Q4 2026 | -3.0% | -5.5% | SQM Sees Lithium Demand Growth but Flags Price and Inventory Risks |
| CTA-PB EIDP, Inc. USD 4.50 Cum Pfd Registered Shs | FY2026 Q3 · Calendar Q3 2026 | — | — | New-product growth held up, but Brazil weakness cut the EBITDA outlook |
| VYLR Vylor Inc. | FY2026 Q3 · Calendar Q4 2026 | +21.1% | -0.1% | Vylor reaffirms 2026 outlook as Brazil licensing model shifts |
| CTVA Corteva, Inc. | FY2026 Q3 · Calendar Q4 2026 | +231.9% | -19.6% | Corteva Q3: New Products Grow as Brazil Weakness Cuts Outlook |
| FNV Franco-Nevada Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.8% | -2.4% | Franco-Nevada Q3: stronger earnings, but revenue missed estimates |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the CTA-PA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-05-08T18:35:03.293523+00:00
- Polygon adjusted daily market bars
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-13. For educational purposes only; not investment advice.